TOKYO and REDWOOD CITY, Calif., Aug. 31, 2024 /PRNewswire/ — ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment […]
Category Archives: Pr Newswire
ABU DHABI, UAE, Aug. 30, 2024 /PRNewswire/ — Ferrari World Yas Island, Abu Dhabi hosted an exclusive preview event on August 29 ahead of the launch of the world’s first Ferrari-themed Esports Arena which is set to officially open to the public in September 2024. The award-winning theme park celebration featured VIPs, media, influencers, and other distinguished […]
Recognized for Completeness of Vision and Ability to Execute SAN FRANCISCO, Aug. 30, 2024 /PRNewswire/ — Anglepoint, the global leader in Software Asset Management (SAM) for the Global 2000, has been positioned by Gartner® as a Leader in the 2024 Magic Quadrant™ for Software Asset Management Managed Services for a fifth time. Once again recognized […]
30
Aug
Aug
NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, […]
Pr Newswire
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
30
Aug
Aug
IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that Arthur Kuan, Chairman & Chief Executive Officer, is scheduled to participate in a fireside chat on Friday, September 6, […]
30
Aug
Aug
WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences: 2024 Wells Fargo Securities Healthcare Conference on […]
30
Aug
Aug
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that on August 26, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 32,250 shares of its common stock to two new non-executive employees to induce them […]
30
Aug
Aug
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference being held in New York, NY […]
BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China rights (including mainland China, Hong Kong, Macau, and Taiwan) of KRAS G12C inhibitor glecirasib and SHP2 inhibitor JAB-3312 to Shanghai Allist Pharmaceuticals Co., Ltd (688578.SH). According to […]
AMSTERDAM, Aug. 30, 2024 /PRNewswire/ — After earning the title of the world’s most valuable dairy brand, according to a new report released by Brand Finance on August 20, Yili has once again secured its spot among the global top five on Rabobank’s annual Global Dairy Top 20 list, which was released on August 26. It […]